NEO
Price
$13.71
Change
+$0.81 (+6.28%)
Updated
Jun 25, 03:39 PM (EDT)
Capitalization
1.68B
41 days until earnings call
Intraday BUY SELL Signals
RDNT
Price
$58.95
Change
+$0.79 (+1.36%)
Updated
Jun 25, 03:40 PM (EDT)
Capitalization
4.58B
47 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NEO vs RDNT

NEO vs RDNT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
NEO vs. RDNT commentary
Jun 25, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEO is a StrongBuy and RDNT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 25, 2026
Stock price -- (NEO: $12.90 vs. RDNT: $58.19)
Brand notoriety: NEO and RDNT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NEO: 246% vs. RDNT: 106%
Market capitalization -- NEO: $1.68B vs. RDNT: $4.58B
NEO [@Medical Specialties] is valued at $1.68B. RDNT’s [@Medical Specialties] market capitalization is $4.58B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $16.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEO’s FA Score shows that 0 FA rating(s) are green whileRDNT’s FA Score has 1 green FA rating(s).

  • NEO’s FA Score: 0 green, 5 red.
  • RDNT’s FA Score: 1 green, 4 red.
According to our system of comparison, RDNT is a better buy in the long-term than NEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEO’s TA Score shows that 4 TA indicator(s) are bullish while RDNT’s TA Score has 5 bullish TA indicator(s).

  • NEO’s TA Score: 4 bullish, 4 bearish.
  • RDNT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, RDNT is a better buy in the short-term than NEO.

Price Growth

NEO (@Medical Specialties) experienced а +24.28% price change this week, while RDNT (@Medical Specialties) price change was +10.17% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +6.66%. For the same industry, the average monthly price growth was +9.84%, and the average quarterly price growth was +3.97%.

Reported Earning Dates

NEO is expected to report earnings on Aug 05, 2026.

RDNT is expected to report earnings on Aug 11, 2026.

Industries' Descriptions

@Medical Specialties (+6.66% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RDNT($4.58B) has a higher market cap than NEO($1.68B). NEO YTD gains are higher at: 9.694 vs. RDNT (-18.444). RDNT has higher annual earnings (EBITDA): 324M vs. NEO (-32.95M). RDNT has more cash in the bank: 455M vs. NEO (146M). NEO has less debt than RDNT: NEO (409M) vs RDNT (1.93B). RDNT has higher revenues than NEO: RDNT (2.14B) vs NEO (746M).
NEORDNTNEO / RDNT
Capitalization1.68B4.58B37%
EBITDA-32.95M324M-10%
Gain YTD9.694-18.444-53%
P/E RatioN/A1425.75-
Revenue746M2.14B35%
Total Cash146M455M32%
Total Debt409M1.93B21%
FUNDAMENTALS RATINGS
NEO vs RDNT: Fundamental Ratings
NEO
RDNT
OUTLOOK RATING
1..100
7916
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
97
Overvalued
PROFIT vs RISK RATING
1..100
10057
SMR RATING
1..100
9592
PRICE GROWTH RATING
1..100
3960
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
n/a39

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NEO's Valuation (59) in the Medical Or Nursing Services industry is somewhat better than the same rating for RDNT (97). This means that NEO’s stock grew somewhat faster than RDNT’s over the last 12 months.

RDNT's Profit vs Risk Rating (57) in the Medical Or Nursing Services industry is somewhat better than the same rating for NEO (100). This means that RDNT’s stock grew somewhat faster than NEO’s over the last 12 months.

RDNT's SMR Rating (92) in the Medical Or Nursing Services industry is in the same range as NEO (95). This means that RDNT’s stock grew similarly to NEO’s over the last 12 months.

NEO's Price Growth Rating (39) in the Medical Or Nursing Services industry is in the same range as RDNT (60). This means that NEO’s stock grew similarly to RDNT’s over the last 12 months.

RDNT's P/E Growth Rating (2) in the Medical Or Nursing Services industry is significantly better than the same rating for NEO (100). This means that RDNT’s stock grew significantly faster than NEO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NEORDNT
RSI
ODDS (%)
Bearish Trend 2 days ago
74%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
72%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
75%
Declines
ODDS (%)
Bearish Trend 10 days ago
82%
Bearish Trend 9 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
64%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
NEO
Daily Signal:
Gain/Loss:
RDNT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EMHY40.640.07
+0.17%
iShares J.P. Morgan EM High Yld Bd ETF
VNIE25.67N/A
N/A
Vontobel International Equity Active ETF
BTOP28.72N/A
N/A
Bitwise Bitcoin and Ether Equal Weight Strategy ETF
TPZ22.10-0.09
-0.39%
Tortoise Electrification Infra ETF
IGM157.20-1.09
-0.69%
iShares Expanded Tech Sector ETF

NEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEO has been loosely correlated with TMO. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if NEO jumps, then TMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEO
1D Price
Change %
NEO100%
+12.47%
TMO - NEO
45%
Loosely correlated
+4.87%
NTRA - NEO
42%
Loosely correlated
+10.74%
A - NEO
42%
Loosely correlated
+3.92%
PSNL - NEO
41%
Loosely correlated
+12.97%
RVTY - NEO
40%
Loosely correlated
+5.74%
More

RDNT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RDNT has been loosely correlated with ITGR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if RDNT jumps, then ITGR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDNT
1D Price
Change %
RDNT100%
+3.54%
ITGR - RDNT
49%
Loosely correlated
+2.05%
GKOS - RDNT
48%
Loosely correlated
+2.31%
NNOX - RDNT
46%
Loosely correlated
+3.97%
ICUI - RDNT
43%
Loosely correlated
+5.42%
CERS - RDNT
42%
Loosely correlated
+2.12%
More